Divi's Laboratories Limited (DIVISLAB) Share Analysis
NSE · Healthcare · Pharmaceuticals
Divi's Laboratories Limited (NSE: DIVISLAB) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 100, NIFTY 200, NIFTY 500. As of 21 Sep 2026, the share price was ₹9,375.00, market capitalisation ₹2,48,877 Cr, P/E 83.5, ROE 16.5%.
Get the AI verdict on DIVISLAB: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
DIVISLAB price and valuation
- Share price
- ₹9,375.00
- Market cap
- ₹2,48,877 Cr
- P/E ratio
- 83.5
- P/B ratio
- 14.86
- EPS
- ₹110.18
- Book value per share
- ₹631.00
- Dividend yield
- 0.32%
DIVISLAB profitability and growth
- ROE
- 16.5%
- ROCE
- 22%
- Debt to equity
- 0
- Revenue growth (3 yr)
- 11%
- Revenue growth (5 yr)
- 9%
- Profit growth (3 yr)
- 13%
- Profit growth (5 yr)
- 6%
DIVISLAB 52-week range
- 52-week high
- ₹9,615.00
- 52-week low
- ₹5,636.50
- Face value
- ₹2.00
DIVISLAB shareholding pattern
- Promoters
- 51.88%
- FIIs
- 20.19%
- DIIs
- 19.29%
- Public
- 8.53%
Index membership: NIFTY 100, NIFTY 200, NIFTY 500, NIFTY Healthcare Index, NIFTY Next 50, NIFTY Pharma, NIFTY Quality 30.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.